Cargando…
Covalent core-radiolabeling of polymeric micelles with (125)I/(211)At for theranostic radiotherapy
Astatine-211 ((211)At) is one of the most promising α-emitters for targeted alpha therapy, especially of cancer metastases. However, the lack of a stable isotope, frequent in vivo deastatination, and limited radiochemical knowledge makes it challenging to apply. Here, we report a new strategy for ra...
Autores principales: | Sporer, Emanuel, Poulie, Christian B. M., Bäck, Tom, Lindegren, Sture, Jensen, Holger, Kempen, Paul J., Kjaer, Andreas, Herth, Matthias M., Jensen, Andreas I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330252/ https://www.ncbi.nlm.nih.gov/pubmed/35912139 http://dx.doi.org/10.7150/ntno.71906 |
Ejemplares similares
-
Synthesis and radiolabeling of a polar [(125)I]I‐1,2,4,5‐tetrazine
por: Bidesi, Natasha, et al.
Publicado: (2022) -
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
por: Lindegren, Sture, et al.
Publicado: (2020) -
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
por: Timperanza, Chiara, et al.
Publicado: (2023) -
Evaluation of therapeutic efficacy of (211)At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
por: Palm, Stig, et al.
Publicado: (2020) -
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with (211)At-mAb
por: Eriksson, Sophie E, et al.
Publicado: (2013)